Robert Kennedy Jr got picked for top health post today which made big-waves across medicine world. His well-known thoughts about shots and drug-costs got pharma folks talking (especially the mega-companies like Novo Nordisk); its clear this might shake things up
The nominee brings some non-standard ideas to the table: his past statements show he doesnt agree with common vaccine science which puts him at odds with most health experts. He also thinks medicine-costs are too high — something that could affect how USA deals with drug makers
The pick might change how other countries work with US health system. European nations whoʼve been good partners in medical research might need to re-think their approach; some experts say this could push more drug development towards American shores
- Big pharma stocks showed quick moves
- Global health groups started asking questions
- European medical firms started planning ahead
This choice comes at an interesting time when obesity drugs are getting bigger in market and vaccine talks are still hot. Kennedyʼs ideas about price-controls might affect companies plans — especially those making new medicines